In particular, our results showed that the increase in serotonin levels induced by SSRIs activates 5-HT1A receptors, and enhances hippocampal neurogenesis and dendritic spine remodeling, thus regulating anxiety and depression behaviors by affecting the nNOS-CAPON interaction. Here, NOS1AP is linked to depressive disorder.